After cancer drug counterfeiting scandal, India imposes new tracing requirements

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.

What the source reports

Reporting by ICIJ and The Indian Express illustrated how Indian counterfeiters exploited the high price of the lifesaving cancer drug Keytruda and the desperation of patients seeking it.

Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.

Source & verification

Primary source: ICIJ · August 5, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.